How to Reconstitute IGF-1 LR3: Step-by-Step Laboratory Protocol
How to Reconstitute IGF-1 LR3: Step-by-Step Laboratory Protocol
IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) represents a synthetic analog of naturally occurring IGF-1, engineered with enhanced stability and extended half-life characteristics. This modified peptide contains 83 amino acids and exhibits reduced binding affinity to IGF binding proteins, making it particularly valuable for in vitro cellular research applications. Laboratory investigations commonly utilize IGF-1 LR3 to examine cellular proliferation mechanisms, metabolic pathway modulation, and protein synthesis regulation in various cell culture systems.
Required Laboratory Materials
IGF-1 LR3 lyophilized powder (1mg vial)
Bacteriostatic water for injection or sterile water for injection
Sterile low-protein-binding microcentrifuge tubes
Calibrated micropipettes (10-1000μL range)
Sterile pipette tips with aerosol barrier
Laminar flow hood or biological safety cabinet
70% isopropyl alcohol for surface sterilization
Sterile gauze pads
Laboratory-grade analytical balance
Vortex mixer (optional)
Refrigerated storage unit (-20°C to +4°C)
Pre-Reconstitution Preparation Protocol
Establish sterile working conditions within a laminar flow hood, ensuring all surfaces undergo thorough decontamination with 70% isopropyl alcohol. Allow the lyophilized IGF-1 LR3 vial to equilibrate to room temperature for approximately 15-20 minutes before initiating reconstitution procedures. This temperature equilibration prevents thermal shock to the peptide structure and reduces condensation formation during solvent addition.
Verify the integrity of all materials and confirm expiration dates on sterile water supplies. Inspect the lyophilized powder for uniform appearance and absence of discoloration, which should present as a white to off-white crystalline material. Calculate the required solvent volume based on desired final concentration using the formula: Volume (mL) = Mass (mg) ÷ Desired Concentration (mg/mL).
Step-by-Step Reconstitution Procedure
Step 1: Remove the plastic cap from the IGF-1 LR3 vial and sterilize the rubber stopper using alcohol-soaked gauze. Allow the alcohol to evaporate completely before proceeding to prevent chemical interference with the peptide.
Step 2: Using a calibrated micropipette, slowly draw the calculated volume of bacteriostatic water or sterile water into a sterile pipette tip. Ensure precise volume measurement for accurate concentration determination.
Step 3: Insert the pipette tip through the rubber stopper at a slight angle to minimize coring. Direct the solvent stream toward the vial wall rather than directly onto the lyophilized powder to prevent foaming and potential peptide degradation.
Step 4: Allow the solvent to slowly dissolve the powder through gentle swirling motion. Avoid vigorous agitation or vortexing, which may compromise peptide integrity through mechanical stress.
Step 5: Continue gentle swirling until complete dissolution occurs, typically within 2-3 minutes. The solution should appear clear and colorless without visible particulates or aggregation.
Step 6: Transfer the reconstituted solution to pre-chilled, sterile low-protein-binding microcentrifuge tubes for aliquoting, minimizing repeated freeze-thaw cycles during subsequent research applications.
Concentration Reference Table
1.0 mL
1.0 mg/mL
10 μg
2.0 mL
0.5 mg/mL
5 μg
5.0 mL
0.2 mg/mL
2 μg
Storage Conditions and Stability
Store reconstituted IGF-1 LR3 solutions at +2°C to +8°C for short-term applications up to 7 days. For extended storage periods, maintain aliquoted samples at -20°C to preserve peptide stability for up to 3 months. Avoid repeated freeze-thaw cycles, which may result in peptide aggregation and reduced biological activity.
Protect stored solutions from direct light exposure and maintain consistent temperature conditions. Label all storage containers with reconstitution date, concentration, and storage temperature requirements for proper laboratory inventory management.
Research Application Notes
Element SARMs recommends conducting preliminary dose-response studies to establish optimal working concentrations for specific cell culture applications. Consider the enhanced potency of IGF-1 LR3 compared to native IGF-1 when designing experimental protocols. Typical working concentrations in cell culture systems range from 10-100 ng/mL, requiring appropriate dilution from stock solutions.
Maintain sterile technique throughout all handling procedures and document reconstitution parameters for reproducible experimental conditions. This reconstitution protocol ensures optimal peptide stability and research reliability for in vitro applications.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML